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Anew Pt(II)complex, [Pt(DIP)(LL)](NO3)2 (inwhich DIP is4,7-diphenyl-1,10-phenanthroline and LL isthealiphatic dinitrogen
ligand, N,N-dimethyl-trimethylenediamine), was synthesized and characterized using diﬀerent physico-chemical methods. The
interaction of this complex with calf thymus DNA (CT-DNA) was investigated by absorption, emission, circular dichroism (CD),
and viscosity measurements. The complex binds to CT-DNA in an intercalative mode. The calculated binding constant, Kb,w a s
6.6 × 104 M−1. The enthalpy and entropy changes of the reaction between the complex and CT-DNA showed that the van der
Waals interactions and hydrogen bonds are the main forces in the interaction with CT-DNA. In addition, CD study showed that
phenanthroline ligand insert between the base pair stack of double helical structure of DNA. It is remarkable that this complex has
the ability to cleave the supercoiled plasmid.
1.Introduction
Cisplatin is one of the most potent antitumor drugs available
for the therapeutic management of solid tumors, such as
germ cell tumors, ovarian, lung, head and neck, and bladder
cancers, and so forth. Despite its wide application as a
chemotherapeutic agent, cisplatin exhibits severe side eﬀects,
such as nephrotoxicity, neurotoxicity, ototoxicity, nausea,
and emetogenicity, which limits the possibilities for gaining
therapeutic beneﬁts from dose intensiﬁcation [1–3]. Thus,
a plethora of Pt(II) and Pt(IV) complexes with nitrogen-
containing ligands has been the subject of intensive bio-
logical evaluation aimed at developing less toxic and more
selective anticancer therapeutics [4, 5]. The DNA-binding
mechanism and behavior of the complexes are closely related
to the size, shape, and planarity of the intercalative ligands.
Besides the above-mentioned factors, ancillary ligands play
an important role in DNA-binding behaviors of complexes.
Propanediaminederivativesofthetype[PtCl2(N-benzyl-1,3-
propanediamine)2]h a v eb e e nr e p o r t e da sp o t e n t i a la n t i t u -
mor agents [6]. In addition, the metal complexes bound to
DNA through the noncovalent interaction generally form
an important subgroup, of which the members are cations
and typically contain ligands bearing extended hydrophobic
areas or surfaces [7]. In recent years, polypyridyl complexes
that can recognize and bind at speciﬁc DNA sites have
received considerable attention [8]. Many eﬀorts have been
directedtowardthedesignofcomplexescontainingmodiﬁed
bipy or phen ligands that bind DNA primarily via base-pair
intercalation [9]. The examples of this category of DNA-
binding agents are metal complexes with polypyridines or
1,10-phenanthrolines (phen) and their derivatives such as
4,7-diphenyl-1,10-phen (DIP) and dipyrido [3,2-a; 29,39-
c]phenazine (dppz) [7].
The application of mixed-ligand complexes permits vari-
ation in the geometry, size, and hydrophobicity by systemat-
ically adjusting the ligands and their substituents and allows
the opportunity to determine how these various factors
contribute to the aﬃnity in DNA binding. By systemically
comparing binding constants and thermodynamic param-
eters for a mixed-ligand complex, we may determine the
contributions of the diﬀerent ligand functionalities and sizes
to the DNA-binding characteristics [10]. The majority of
research in this ﬁeld has focused on the use of polypyridine
derivatives such as 2,2 -bipyridine and 1,10-phenanthroline
as ligands [11–14].2 Bioinorganic Chemistry and Applications
Therefore,todesignimproveddrugsthattargetDNAand
to investigate the eﬀect of mixed-ligand complexes on the
structure and conformation of DNA, we used a Pt(II) com-
plex, [Pt(DIP)(LL)](NO3)2 (in which DIP is 4,7-diphenyl-
1,10-phenanthroline and LL is the aliphatic dinitrogen lig-
and, N,N-dimethyl-trimethylenediamine). Binding studies
of this complex with calf thymus DNA (CT-DNA) were
studied by electronic absorption spectroscopy, ﬂuorescence
spectroscopy, circular dichroic spectral, viscosity measure-
ments, and electrophoresis.
2. Experimental
2.1. Materials. 4,7-diphenyl-1,10-phenanthroline (DIP), N,
N-dimethyltrimethylenediamine, hydrazine dihydrochlo-
ride, potassium Chloride, nitric acid, Tris-acetate-EDTA
(TAE) buﬀer, hydrogen peroxide, NaN3, and Tris-HCl were
purchased from Merck. Doubly distilled deionized water was
used throughout. Highly polymerized CT-DNA and pUC19
DNA was also purchased from Sigma and used without
puriﬁcation.
Experiments were carried out in Tris-HCl buﬀer at
pH 7.2. A solution of calf thymus DNA gave a ratio of UV
absorbance at 260 and 280nm more than 1.8, indicating that
DNA was suﬃciently free from protein. The stock solution
of CT-DNA was prepared by dissolving of DNA in 10mM
of the Tris-HCl buﬀer at pH 7.2. The DNA concentration
(monomer units) of the stock solution (1 × 10−2Mp e r
nucleotide) was determined by UV spectrophotometer, in
properly diluted samples, using the molar absorption coef-
ﬁcient 6600M−1cm−1 at 258nm [15]. The stock solutions
were stored at 4◦C and used over no more than 4 days.
2.2. Synthesis of Platinum Complex
2.2.1. Synthesis of Pt(DIP)Cl2 [16]. Pt(DIP)Cl2 complex
(DIP = chelating diamin ligand: 4,7-diphenyl, 1,10-phenan-
throline) were synthesized by boiling of K2PtCl4 (1.0g) and
DIP ligand (0.5g) in 1.5mL of water containing 0.5mL
of HCl. After 20h, the reaction mixture was allowed to
cool to room temperature and the light green product that
precipitated was ﬁltered out, washed with hot water and
dried under vacuum. Yield: 1.04g (97%).
2.2.2. Synthesis of [Pt(DIP)(LL)](NO3)2. Pt(DIP)Cl2 (0.08g,
0.167mmol) was dissolved in 2mL of DMF. A solution
of silver nitrate (0.056g, 0.333mmol) in 1mL of DMF
was added and the mixture was stirred overnight at room
temperature in the dark. The precipitate was ﬁltered oﬀ
and LL ligand (LL = N,N-dimethyltrimethylenediamine)
(0.017g, 0.167mmol) was added to the ﬁltrate. The mixture
was stirred for 4 days at room temperature in the dark.
The product was washed with a small amount of ethanol
and dried under vacuum. Yield: 0.041g (47%). 1HN M R
(ppm, CDCl3): 7.48(Ph); H1  (9.58); H2  (8.07); H3  (8.01);
1CH2(3.03); 2CH2(1.86); 3CH2(2.46); NH2(2.16); Me(2.41).
Anal. Calc. for PtC29N4 H30: C, 55.32; H, 4.80; N, 8.90;
Found: C, 55.11; H, 5.1; N, 8.69%. FT-IR data (Cm−1): 3309,
2935, 1664, 1577, 1439, 548, 420.
2.3. Instrumentation. 1H NMR spectra were recorded using
a Bruker Avance DPX200MHz (4.7 Tesla) spectrometer with
CDCl3 as the solvent. The elemental analysis was performed
using a Heraeus CHN elemental analyzer. The molar con-
ductance of complexes was measured in DMF at room
temperature on an ELICO (CM 82T) conductivity bridge.
Absorbance spectra were recorded using an HP spec-
trophotometer (Agilent 8453) equipped with a thermostated
bath (Huber polysat cc1). Absorption titration experiments
were conducted by keeping the concentration of complexes
constant(5 ×10−5 M),whilevaryingtheDNAconcentration
from 0 to 1 × 10−4 M( ri = [DNA]/[complex] = 0.0,
0.1,0.6,1,1.5 , 2 ) .A b s o r b a n c ev a l u e sw e r er e c o r d e da f t e r
each successive addition of DNA solution, followed by an
equilibration period. In order to obtain a more quantitative
determination of the interaction strength, intrinsic-binding
constant, Kb, was determined using spectroscopic titration
data at 230nm. The data were then ﬁtted to (1) to obtain the
binding constant [17],
[DNA] 
εa −εf
 =
[DNA] 
εb −εf
 +
1
Kb

εb −εf
,( 1 )
where εa, εf,a n dεb, are the apparent, free, and bound metal
complex extinction coeﬃcients, respectively. In particular,
εf was determined by a calibration curve of the isolated
metal complex in aqueous solution, following the Beer’s
law. εa was determined as the ratio between the measured
absorbance and the Pt(II) complex concentration, Aobs/
[complex]. A plot of [DNA]/(εb − εf) versus [DNA] gave a
slope of +1/(εb−εf)a n daY intercept equal to 1/Kb(εb−εf);
Kb is the ratio of the slope to the Y intercept.
Viscosity measurements were made using a viscosimeter
(SCHOT AVS 450) that was maintained at 25 ± 0.5◦C using
a constant temperature bath. The DNA concentration was
ﬁxed at 5 × 10−5M, and ﬂow time was measured with
a digital stopwatch. The mean values of three replicated
measurements were used to evaluate the viscosity η of the
samples. The values for relative speciﬁc viscosity (η/ηo)1/3,
where ηo and η are the speciﬁc viscosity contributions of
DNA in the absence (ηo), and in the presence of the Pt
(II) complex (η) were plotted against ri (ri = [complex]/
[DNA] = 0.0,0.1,0.3,0.6,0.9,1.2) [18].
Fluorescence measurements were carried out with a
JASCO spectroﬂuorimeter (FP 6200) by keeping the con-
centration of complex constant (5 × 10−5M) while varying
the DNA concentration from 0 to 6 × 10−5M. (ri = [DNA]/
[complex] = 0.0, 0.4, 0.6, 0.8, 1, 1.2) at three diﬀerent
temperatures(283,288,310K).Stern-VolmerConstant(Ksv)
is used to evaluate the ﬂuorescence quenching eﬃciency.
According to the classical Stern-Volmer equation:
F0
F
= 1+Kqτ0[Q] = 1+Ksv[Q],( 2 )
where F0 and F represent the ﬂuorescence intensities in the
absence and in the presence of quencher, respectively. Kq is
the quenching rate constant of biomolecule, Ksv the dynamic
quenching constant, τ0 is the lifetime of the biomoleculeBioinorganic Chemistry and Applications 3
without quencher (τ0 = 10−8), and [Q] is the concentration
of quencher.
CD measurements were recorded on a JASCO (J-810)
spectropolarimeter by keeping the concentration of DNA
constant (5 × 10−5M) while varying the complex concentra-
tion from 0 to 4 × 10−5M( ri = [complex]/[DNA] = 0,0.2,
0.4,0.6,0.8).
2.4. Cleavage Eﬃciency. The DNA cleavage activity of the
metal complex was studied by using agarose gel elec-
trophoresis.SupercoiledplasmidpUC19DNA(50μmol)was
dissolved in a 0.050mol Tris-(hydroxymethyl) methane-HCl
(Tris-HCl) buﬀer (pH 7.2) containing 0.050mol NaCl and
the diﬀerent concentration of complexes (100, 200, 300, and
400μmol). The mixtures were incubated at 37◦Cf o r2 4 h
and then mixed with the loading buﬀer (2μL) containing
25% bromophenol blue, 0.25% xylene cyanol, and 30%
glycerol. Each sample (5μL) was loaded into 0.8% w/v
agarose gel. Electrophoresis was undertaken for 1h at 50V
in Tris-acetate-EDTA (TAE) buﬀer. The gel was stained with
ethidium bromide for 5min after electrophoresis, and then
photographed under UV light. The proportion of DNA in
each fraction was quantitatively estimated from the intensity
of each band with the Alpha Innotech Gel documentation
system (AlphaImager 2200). To enhance the DNA-cleaving
ability by the complexes, hydrogen peroxide (100μmol) was
added into each complex (400μmol). Moreover, the cleavage
mechanism was further investigated by using scavengers for
the hydroxyl radical species (4μL, DMSO) and the singlet
oxygen species (100μmol, NaN3). All experiments were
carried out in triplicate under the same conditions.
3. Results andDiscussions
3.1. Synthesis and Characterization of Platinum Complex.
The platinum complex, [Pt(DIP)(LL)](NO3)2 in which LL =
N,N-dimethyltrimethylenediamine and DIP = 4,7-diphenyl-
1,10-phenanthroline, was synthesized from reaction of
K2PtCl4 and diimine ligands (Scheme 1)a n dc h a r a c t e r i z e d
byUV-Vis,IRandNMRspectroscopicmethodsandelemen-
tal analysis.
The 1H NMR Labeling is shown in Figure 1.T h e1H
NMR spectrum (Figure 2(a)) has shown proton signals at
aliphatic (0–4ppm) and aromatic (7–10ppm) regions. The
ring current of 4,7-diphenyl-1,10-phenanthroline (DIP) lig-
and with shielding due to nonbonded interaction of protons
with metal causes a complex resonance pattern at low
ﬁeld. The feature specially led to some coupling of alpha
protons with 195Pt and so that signal shift to higher ﬁeld.
Therefore, the set of signals of aromatic and aliphatic ligands
shift to higher ﬁeld this is characteristic for attaching the
ligand to platinum metal. The unsymmetrical structure of
the platinum complex causes that the chemically equivalent
protons of phenanthroline ligand resonance at diﬀerent
chemical shifts. 1H NMR chemical shifts of the free ligands
and platinum complex are shown in Table 1. The absorption
spectrum of the Pt(II) complex is shown in Figure 2(b).I n
the UV region, the complex exhibits two intense absorp-
tion bands around 237 and 280nm which is attributed to
n → π∗ and π → π∗ transitions of dinitrogen ligands.
The MLCT band is observed in visible region around
430nm. Therefore, the absorption spectrum conﬁrms the
suggested structure for the platinum complex. The FT-IR
spectrum of the Pt(II) complex is shown in Figure 2(c).
The coordination of the nitrogen atoms is conﬁrmed with
the presence of two bands at 548 and 420cm−1, assignable
to ν(Pt-N) for aliphatic and aromatic ligands, receptively.
Furthermore, the appearance of two bands around 1577–
1664cm−1 is indicative of bending vibration of N–H groups.
The broad band of N–H stretching vibration is also observed
at 3309cm−1. The bands around 1439 and 1577cm−1 can
be attributed to the ring stretching frequencies [ν (C=C)
and ν (C=N)] of phenanthroline ligand. The bands around
2935cm−1 can be assigned to C–C stretching vibration of
aliphatic CH2 groups of aliphatic ligand.
3.2. Electronic Absorption Spectral Studies. In general, hypo-
chromism and redshift are associated with the binding of
the complex to the helix by an intercalative mode involving
strong stacking interaction of the aromatic chromophore of
the complex between the DNA base pairs. Figure 3 shows
the UV absorption spectra of Pt(II) complex in the absence
and presence of CT-DNA. The absorption intensity of
the complex increased (hyperchromism) evidently after the
addition of DNA, which indicated the interactions between
DNA and the complex.
The Pt(II) complex can be bind to double-stranded DNA
in diﬀerent binding modes on the basis of the structure and
type of the ligands. As DNA-double helix possesses many
hydrogenbindingsiteswhichareaccessiblebothintheminor
and major grooves, it is likely that the amine group of
aliphatic ligand in the Pt(II) complex forms hydrogen bands
with DNA, which may contribute to the hyperchromism
observed in the absorption spectra. On the other hand,
our platinum complex, which possesses methylene groups
of the aliphatic diamine ligand (LL) can be bind to DNA
by van der Waals interaction between the methylene groups
and the thymine methyl group [19]. The hyperchromic
eﬀect may also be due to the electrostatic interaction
between positively charged cation and the negatively charged
phosphatebackboneattheperipheryofthedoublehelix-CT-
DNA [20]. In the titled complex, the complete intercalation
of phenanthroline ligands between set of adjacent base pairs
is sterically impossible, but some type of partial intercalation
can be envisioned [21]. But this needs further clariﬁcation
of the DNA-binding mode of the complex by viscosity
measurements.
The calculated Kb value was found to 6.6 × 104 M−1.
The values of Kb described in the literature for classical
intercalators (ethidium-DNA, 7 × 107 M−1), [22] (proﬂavin-
DNA, (4.1 × 105 M−1)[ 23] are at least ten order in
magnitudehigherthanthatofthisPt(II)complex.Thisresult
suggests that intercalation between base pairs is not the main
modeofinteractionofPt(II)complexwithDNA.Incontrast,
the value of Kb is ten order in magnitude higher than Kb
values which found for compounds with the mode of groove
binding to DNA like Cr(III) complexes [24] or Tris (1,10-
phen) ruthenium (II) to DNA [25]. Theses results conﬁrm4 Bioinorganic Chemistry and Applications
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Scheme 1
Table 1: 1H NMR chemical shifts of 4,7-diphenyl-1,10-phenanthroline (DIP) and N,N-dimethyltrimethylenediamine ligand (LL) and
[Pt(DIP)(LL)](NO3)2 complex.
Protons Ph H
1 
H
2 
H
3  1CH2
2CH2
3CH2 NH2 Me
DIP 7.8 9.7 8.2
LL 3.23 2.01 2.52 2.3 2.68
∗[Pt(DIP)(LL)]2+ 7.48, 7.6 9.58, 9.61 8.07, 8.11 8.01, 8.03 3.03 1.86 2.46 2.16 2.41
Ph
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ME ME
N
N N
N
CH2
CH2
H2C
1
2
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3
H H
Figure 1: The structure and 1H NMR labeling of the
[Pt(DIP)(LL)](NO3)2 complex.
that the platinum complex strongly interact with DNA, the
Kb value of this complex is similar to ZnL2+ complex in
analogue condition (Kb = 7.35 × 104 M−1) which considered
as an intercalating complex [26].
Furthermore, the Kb value obtained for our complex is
lower than some platinum complexes which suggested as
intercalators and have similar structures such as [Pt(en) (5,
6-Me2-Phen)]Cl2 (Kb = 1.5 × 106); [Pt(en)(3,4,7,8-Me4-
Phen)]Cl2 (Kb = 7 × 105)[ 27].
From the results, we can deduce that the platinum
complex bind to DNA by intercalation and the weaker
DNA binding of the complex may arise from the steric
eﬀect of the phenyl groups on phenanthroline ligands which
hinder the complete insertion of DIP ligand between the
DNA base pairs. This type of steric clash has been also
suggested for the binding of [Ru(5,6-dmp)(NH3)4]2+ [28]
and [{5,6-dmp)2Ru}2(bmp)]4+ [29].
Therefore, we suggest that the present platinum complex
bind to DNA most probably through intercalation, but to
further clariﬁcation of the DNA-binding mode, viscosity
measurements should be done.
3.3. Viscosity Studies. It is known that the classical organic
intercalator, Ethidium bromide, increases the axial length of
the DNA and it becomes more rigid, resulting in an increase
in the relative viscosity. Results conﬁrm the sensitivity of
viscosity measurements to the diﬀerent modes of DNA
binding. The values of relative speciﬁc viscosity (η/η◦)1/3
(η◦ and η are the speciﬁc viscosity contributions of DNA
in the absence and in the presence of the present complex)
were plotted against 1/R (R = [DNA]/[complex]) (Figure 4).
In the viscosity curve the results indicate that the absence
and the presence of the metal complex have a marked eﬀect
on the viscosity of the DNA. The speciﬁc viscosity of the
DNA sample increases obviously with the addition of the
complex. The viscosity studies provide a strong argument for
intercalation[30,31].Ther elati v evisc osityo fDN Aincr eases
with increase in the concentration of Pt(II) complex which
is ascribed to the intercalative binding mode of the complex
because this could cause the eﬀective length of the DNA to
increase [32, 33]. In essence, the length of the linear piece of
B-form DNA is given by the thickness of the base pairs that
are stacked along the helix axis in van der Waals contact with
each other introducing another aromatic molecule into the
stack, therefore, the increase of the DNA caused by addition
of the complex can provide further support for intercalative
mode of the platinum complex binding. It was observed that
increasing the platinum complex concentration led to an
increase of the DNA viscosity. Thus, we may deduce that the
mentionedcomplexcanbeconsideredasaDNAintercalator.
Li et al. [34] showed that EB increased the relative viscos-
ity of DNA and the slope of the graph of (η/η◦)1/3 versus 1/R
was 0.96, which is very close to value of 1.0 predicted from
the theory of Satyanarayana et al. [35]. Since the intercalative
interaction of this Pt(II) complex with DNA can make DNA
longer, we would expect that the relative viscosity of DNA
increases with a slope between 0 and 0.96 (a value measured
for EB) if the intercalation of the Pt(II) complex was either
only one interaction mode or much stronger than other
interaction(s). But in this study the relative viscosity of DNA
increase with a slope of 0.46 and it is reasonably believedBioinorganic Chemistry and Applications 5
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Figure 2: (a) 1H NMR spectrum, (b) UV-vis spectrum, and (c) FT-IR spectrum of the platinum complex.
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that may be other interaction(s) between DNA and the Pt(II)
complex occurred and is responsible for the decrease of the
slope. In addition, the greater increase in viscosity observed
for EB compared to the Pt(II) complex is likely due to the
lower binding constant of the latter to DNA. These results
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Figure 4: Eﬀect of increasing amounts of complex on the viscosity
of CT-DNA (5 × 10−5 M) in 10mM Tris-HCl.
clearly show the importance of using several techniques to
ascertain intercalation.
3.4. Fluorescence Studies. Fluorescence quenching can occur
by diﬀerent mechanisms, which are usually classiﬁed as dy-
namic quenching and static quenching. In general, dynamic
and static quenching can be distinguished by their diﬀering6 Bioinorganic Chemistry and Applications
Table 2: The quenching constants of Pt (II) complex by CT DNA
at diﬀerent temperatures ranging from 0–5 × 10−5mol L−1 of CT
DNA.
T (K) R2 Ksv (Lmol−1) × 103 Kq (Lmol−1) × 1011
283 0.958 13.615 13.615
288 0.997 17.268 17.268
310 0.992 23.126 23.126
dependence on temperature and excited state lifetime [36,
37].
The eﬀect of DNA on Pt(II) complex ﬂuorescence inten-
sity is shown in Figure 5. As shown in this ﬁgure, upon the
addition of CT-DNA, an obvious decrease in emission
intensity was observed for the complex. This implies that the
titled complex has an interaction with DNA. Furthermore,
the quenching of luminescence of Pt(II) complex by CT-
DNA may be attributed to the photoelectron transfer from
guanine base of DNA to the excited MLCT state, as reported
in the case of some complexes [38–40]. The plots of F0/F
v e r s u sD N Aa td i ﬀerent temperatures are shown in Figure 6.
As mentioned in the literature, dynamic quenching or
collisional quenching requires contact between the excited
ﬂourophore and the quenching specie, the quencher. The
other form of quenching is static quenching in which the
quencher and the ﬂuorophore in ground state form a stable
complex. Fluorescence is only observed from the unbound
ﬂuorophore [41].
Byusing(2),theKsv ofPt(II)complexformationbyDNA
at diﬀerent temperatures (283, 288, and 310K) was obtained
and the results are shown in Table 2. These results show
that the probable quenching mechanism of Pt(II) complex
formation by DNA is a dynamic quenching procedure,
because the Ksv has been increased by temperature rising
[42].
3.4.1. Binding Constants and Binding Sites. The binding con-
stant(Kf)andthebindingstoichiometry(n)forthecomplex
formation between Pt(II) complex and DNA was measured
using the following equation: [43],
log(F0 −F)
F
= logKf +n log[DNA]. (3)
Here F0 and F are the ﬂuorescence intensities of the ﬂu-
orophore in the absence and in the presence of diﬀerent
concentrations of DNA, respectively. The linear equations
of log(F − F0)/F versus log[DNA] at diﬀerent temperature
are shown in Table 3.T h ev a l u e so fKf clearly underscore the
aﬃnity of Pt(II) complex to DNA.
3.4.2. Thermodynamic Studies. The interaction forces bet-
ween drug and biomolecule may involve hydrophobic forces,
electrostatic interactions, van der Waals interactions, hydro-
gen bonds, and so forth [44, 45]. According to the data
of enthalpy changes (ΔH) and entropy changes (ΔS), the
model of interaction between drug and biomolecule can be
concluded [46]: (1) ΔH>0a n dΔS>0, hydrophobic
forces; (2) ΔH<0a n dΔS<0, vander Waals interactions
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Figure 5: Fluorescence spectra of Pt(II) complex in the presence of
various concentrations of CT DNA.
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Figure 6: Plots of F0/F versus [Q] for the binding of Pt(II) complex
with CT DNA.
and hydrogen bonds; (3) ΔH<0a n dΔS>0, electrostatic
interactions [47]. In order to elucidate the interaction of
Pt(II) complex with DNA, the thermodynamic parameters
were calculated. The plot of lnK versus 1/T (4) allows the
determination of enthalpy change (ΔH) and entropy change
(ΔS). If the temperature does not vary signiﬁcantly, the
enthalpy change (ΔH) can be regarded as a constant. Based
on the binding constants at diﬀerent temperatures, the free
energy change (ΔG)c a nb ee s t i m a t e d( Table 3; (5)) by the
following equations:
lnK =−
ΔH
RT
+
ΔS
R
,
ΔG = ΔH −TΔS =− RT lnK,
(4)Bioinorganic Chemistry and Applications 7
Table 3: Binding constants (Kf), number of binding sites (n), and thermodynamic parameters of the Pt (II)-DNA system.
T(K) n Log Kf Kf R2 ΔG0 (kJ mol−1) ΔH0 (kJ mol−1) ΔS0 (Jmol−1K◦−1)
283 1.74 7.289 1.9 × 107 0.94 −186.42 −111.79 −263.66
288 1.421 5.965 9.22 × 105 0.994 −187.72 −111.79 −263.66
310 1.191 5.162 14.5 × 104 0.987 −193.52 −111.79 −263.66
where K is the Stern-volmer quenching constant at the
corresponding temperatures and R is the gas constant. When
weapplythisanalysistothebindingsystemofPt(II)complex
and CT-DNA, we ﬁnd that ΔH<0a n dΔS<0. Therefore,
van der Waals interactions or hydrogen bonds are the main
forces in the binding of the investigated Pt(II) complex
to CT-DNA, and the mode of binding is intercalation.
In addition, the negative entropy change results from the
intercalation of Pt(II) complex between CT-DNA bases,
accompanied by the loss of translational and rotational
degrees of freedom.
3.5. Circular Dichroic Spectral Studies. The CD spectral tech-
nique is useful in monitoring the conformational variations
of DNA in solution. The observed CD spectrum of natural
DNA consists of a positive band at 275nm due to base
stacking and a negative band at 245nm due to helicity, which
is characteristic of DNA in right-handed B form (Figure 7)
[48].
The eﬀect of [Pt(DIP)(LL)](NO3)2 complex on the con-
formation of secondary structure of CT-DNA was studied by
keeping the concentration of CT-DNA at 5 × 10−5M−1 while
varying the concentration of platinum complex in a buﬀer
solution of 10mM Tris was added, (ri = 0.2,0.4,0.6,0.8). In
the presence of the complex both positive and negative peaks
of CD spectra of DNA increased (Figure 7). The changes
in ellipticity and wavelength caused by platinum complex
is signiﬁcant and addition of the complex to DNA solution
results, both before and after illumination, in a signiﬁcant
and dose-dependent increase of the positive and negative
dichroic bands accompanied by a shift to lower energy
(redshift). This behavior could be attributed to the insertion
of phenanthroline ligand between the base-pair stack of
double-helical structure of the DNA. Moreover, the observed
increase of the hyperchromicity as well as of the ellipticity
following illumination shows the promise of our platinum
complex as a photodynamic therapy agent. Thus, further
studies to verify the photo-cleavage of DNA in the presence
of oxygen should be done.
3.6. DNA Cleavage Activity. The degree to which the plat-
inum complex could function as DNA cleavage agent was
examined using supercoiled pUC19 plasmid DNA as the
target. The eﬃciency of cleavage of the molecule was probed
using agarose gel electrophoresis. When circular plasmid
DNA is conducted by electrophoresis, the fastest migration
will be observed for the supercoiled form (Form I). If one
strand is cleaved, the supercoil will relax to produce a slower-
moving nicked circular form (Form II). If both strands are
cleaved, a linear form (Form III) will be generated that
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Figure 7: Circular dichroism spectra of CT DNA (5 × 10−5 M)
in Tris-HCl (10mM), in the presence of increasing amounts of
the complex at the following stoichiometric ratios: ri = [com-
plex]/[DNA] = 0.0, 0.2, 0.4, 0.6, and 0.8.
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Figure 8: Cleavage of SC pUC19 DNA (50μM) by platinum com-
plex (100μM) in the presence of H2O2 (100μM), in 10 mM Tris-
HCl/1mMEDTAbuﬀer(pH8.0).lane1:DNAMarker;lane2:DNA
control; lane 3: DNA + complex; lane 4: DNA + complex 1 + H2O2;
lane 5: DNA + complex + H2O2 +D M S O( 4μL); lane 6: DNA +
c o m p l e x1+H 2O2 +N a N 3 (100μM).
migrates in between. The platinum complex was found
to promote the cleavage of pUC19 plasmid DNA from
supercoiled Form (I) to the nicked Form (II) by varying
the concentration (100–400μM, ﬁgure not presented). The
complexes can induce the obvious cleavage of the plasmid
DNA at the concentration of 100μM.
One of the most interesting electrophoretic results of the
complex takes place when experiment done in presence of
H2O2, where the cleavage of the supercoiled DNA Form (I)
into nicked DNA Form (II) take place more than complex
alone. The mechanism of pUC19 DNA cleavage by our com-
plex was then in the presence of studied by implementing
various inhibiting reagents. The eﬀect of reactive oxygen
species on this process was tested with standard hydroxyl
radical scavenger (DMSO) and singlet oxygen scavenger
(NaN3). DMSO (lane 5 in Figure 8) remarkably inhibited8 Bioinorganic Chemistry and Applications
the DNA breakage (36–40%) induced by the complexes
(100μM). Interestingly, the singlet oxygen scavenger NaN3
failed to protect the DNA from the platinum complex
induced cleavage almost (lanes 6 in Figure 8), which suggests
that singlet oxygen does not play an important role in
the cleavage mechanism pathway. In summary, these results
indicate that the cleavage reaction involves hydroxyl radicals,
that is, a Fenton type reaction may leads to the formation of
these oxygen active species which ﬁnally cleave the DNA.
4. Conclusions
We recently investigated the interaction of PtCl2(NN)
complex (NN = 4,7-dimethyl-1,10 phenanthroline) [49],
[PtCl2(DIP)] [50] and [PtCl2(LL)] in which LL = N,N-
Dimethyl-trimethylenediamine [51] with CT-DNA. The
addition of solvents other than water, though, ensure sol-
ubility of those complexes, increases the hydrophobicity
of the bulk solvent, which in turn decreases the DNA
binding ability of the complexes. In the present study this
diﬃculty has been overcome by using a water soluble
complex, [Pt(DIP)LL)]+2 such a ligand modiﬁcation would
also provide us an opportunity to obtain addition structural
insight into the binding event. In this study, we have
synthesized a new Pt(II) complex, [Pt(DIP)(LL)](NO3)2
(in which DIP is 4,7-diphenyl-1,10-phenanthroline and
LL is the aliphatic dinitrogen ligand, N,N- Dimethyl-tri-
methylenediamine) which exhibits high binding aﬃnity
to CT-DNA and the following results supported the fact
that the complex can bound to CT-DNA by the mode of
intercalation.
(1) In absorption spectrum, the absorption intensity of
the complex increased (hyperchromism) evidently
after the addition of DNA, which indicated the inter-
actions between DNA and the complex. The intrinsic
binding constant (Kb = 6.6 × 104 M−1)i sr o u g h l y
comparable to other intercalators [29]. Interestingly,
the Kb value obtained for our complex is higher
thanthatoftheotherplatinumcomplex[PtCl2(NN)]
(Kb = 6.35 × 104)[ 49]. Therefore, the binding
constantindicatesthatourcomplexcanbindstrongly
with DNA.
(2) The relative viscosity of DNA increases with increase
in the concentration of Pt (II) complex which is
ascribed to the intercalative binding mode of the
complex because this could cause the eﬀective length
of the DNA to increase [38, 39].
(3) Fluorescence studied results show that the probable
quenching mechanism of Pt(II) complex formation
by DNA is a dynamic quenching procedure, because
theKsv hasbeenincreasedbytemperaturerising[49].
Thermodynamic studies showed that ΔH<0a n d
ΔS<0. Therefore, van der Waals interactions or
hydrogen bonds are the main forces in the binding
of the investigated Pt(II) complex to CT-DNA, and
the mode of binding is intercalation.
(4) Circular dichroism results showed deep conforma-
tional changesof CT-DNAdouble helix following the
interaction with the complex.
(5) The platinum complex was found to promote the
cleavage of pUC19 plasmid DNA from supercoiled
Form (I) to the nicked Form (II) by varying the
concentration (100–400μM, ﬁgure not presented).
Thecomplexescaninducetheobviouscleavageofthe
plasmid DNA at the concentration of 100μM.
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